-
1
-
-
84864194217
-
European payer initiatives to reduce prescribing costs through use of generics
-
B. Godman, B. Wettermark, I. Bishop, T. Burkhardt, J. Fürst, and K. Garuoliene European payer initiatives to reduce prescribing costs through use of generics GaBI J 1 2012 22 27
-
(2012)
GaBI J
, vol.1
, pp. 22-27
-
-
Godman, B.1
Wettermark, B.2
Bishop, I.3
Burkhardt, T.4
Fürst, J.5
Garuoliene, K.6
-
3
-
-
33947267465
-
Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals
-
K. Andersson, G. Bergstrom, M. Petzold, and A. Carlsten Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals Health Policy. 81 2007 376 384
-
(2007)
Health Policy.
, vol.81
, pp. 376-384
-
-
Andersson, K.1
Bergstrom, G.2
Petzold, M.3
Carlsten, A.4
-
4
-
-
78650875380
-
GPs save £400m in 2008 by increasing use of generic drugs
-
R. Coombes GPs save £400m in 2008 by increasing use of generic drugs BMJ 338 2009 b2044
-
(2009)
BMJ
, vol.338
, pp. 2044
-
-
Coombes, R.1
-
5
-
-
84883465988
-
GPhA report: Savings: $1 trillion over 10 years - Generic drug savings in the U.S
-
Generic Pharmaceutical Association
-
Generic Pharmaceutical Association GPhA report: savings: $1 trillion over 10 years - generic drug savings in the U.S J Pharm Health Serv Res 3 2012 229 236
-
(2012)
J Pharm Health Serv Res
, vol.3
, pp. 229-236
-
-
-
6
-
-
84871808597
-
Generic Medicines: Essential Contributors to the Long-Term Health of Society
-
Accessed 4.02.13
-
Sheppard A. Generic Medicines: Essential Contributors to the Long-Term Health of Society. IMS Health. Available at: http://www.imshealth.com/imshealth/ Global/Content/Document/Market-Measurement-TL/Generic-Medicines-GA.pdf. Accessed 4.02.13.
-
IMS Health
-
-
Sheppard, A.1
-
8
-
-
77955576790
-
Use of generics - A critical cost containment measure for all healthcare professionals in Europe?
-
B. Godman, W. Shrank, and B. Wettermark Use of generics - a critical cost containment measure for all healthcare professionals in Europe? Pharmaceuticals 3 2010 2470 2494
-
(2010)
Pharmaceuticals
, vol.3
, pp. 2470-2494
-
-
Godman, B.1
Shrank, W.2
Wettermark, B.3
-
10
-
-
34249848744
-
-
European Generic Medicines Association (EGA) Available at: Accessed 18.05.13
-
European Generic Medicines Association (EGA) Frequently Asked Questions About Generic Medicines 2007 Available at: http://198.170.119.137/doc/FAQ- generics.pdf Accessed 18.05.13
-
(2007)
Frequently Asked Questions about Generic Medicines
-
-
-
11
-
-
77951806024
-
Creating sustainable European health-care systems through the increased use of generic medicines: A policy analysis
-
S. Simoens Creating sustainable European health-care systems through the increased use of generic medicines: a policy analysis J Generic Med: Business J Generic Med Sec 7 2010 131 137
-
(2010)
J Generic Med: Business J Generic Med Sec
, vol.7
, pp. 131-137
-
-
Simoens, S.1
-
12
-
-
84874824355
-
The impact of pharmaceutical pricing and reimbursement policies on generics uptake: Implementation of policy options on generics in 29 European countries-an overview
-
S. Vogler The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries-an overview GaBI J 1 2012 93 100
-
(2012)
GaBI J
, vol.1
, pp. 93-100
-
-
Vogler, S.1
-
13
-
-
77953722299
-
Controversy over generic substitution
-
R.E. Ferner, W. Lenney, and J.F. Marriott Controversy over generic substitution BMJ 340 2010 c3570
-
(2010)
BMJ
, vol.340
, pp. 3570
-
-
Ferner, R.E.1
Lenney, W.2
Marriott, J.F.3
-
15
-
-
84883453417
-
-
International Society of Drug Bulletins (ISDB) 20(3 (special issue on INN))
-
International Society of Drug Bulletins (ISDB) ISDB Newsletter 2006 20(3 (special issue on INN))
-
(2006)
ISDB Newsletter
-
-
-
16
-
-
69249239312
-
-
National Prescribing Service Limited (NPS) Available at: Accessed 9.05.13
-
National Prescribing Service Limited (NPS) Generic Medicines: Same Difference? 2006 Available at: http://www.nps.org.au/-data/assets/pdf-file/0020/ 15842/news44-generic-medicines-0206.pdf Accessed 9.05.13
-
(2006)
Generic Medicines: Same Difference?
-
-
-
17
-
-
77956407438
-
-
National Prescribing Service Limited (NPS) Available at: Accessed 9.05.13
-
National Prescribing Service Limited (NPS) Generic Medicines: Dealing with Multiple Brands 2007 Available at: http://www.nps.org.au/-data/assets/pdf- file/0008/23867/news55-generic-medicines-1207.pdf Accessed 9.05.13
-
(2007)
Generic Medicines: Dealing with Multiple Brands
-
-
-
18
-
-
77955741424
-
Generic and therapeutic substitutions in the UK: Are they a good thing?
-
M.G. Duerden, and D.A. Hughes Generic and therapeutic substitutions in the UK: are they a good thing? Br J Clin Pharmacol 70 2010 335 341
-
(2010)
Br J Clin Pharmacol
, vol.70
, pp. 335-341
-
-
Duerden, M.G.1
Hughes, D.A.2
-
19
-
-
84883453084
-
-
U.S. Department of Health and Human Services-FDA/CDER Available at: 32: Accessed 10.01.13
-
U.S. Department of Health and Human Services-FDA/CDER Office of Generic Drugs. Orange Book: Approved Drug Prod Ther Equivalence Evaluations 2012 Available at: 32: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/ UCM071436.pdf Accessed 10.01.13
-
(2012)
Office of Generic Drugs. Orange Book: Approved Drug Prod Ther Equivalence Evaluations
-
-
-
20
-
-
78649372017
-
Generic drugs: The benefits and risks of making the switch
-
P. Lewek, and P. Kardas Generic drugs: the benefits and risks of making the switch J Fam Pract 59 2010 634 640
-
(2010)
J Fam Pract
, vol.59
, pp. 634-640
-
-
Lewek, P.1
Kardas, P.2
-
21
-
-
80052808963
-
ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: A report of the American College of Cardiology Foundation Clinical Quality Committee
-
D.R. Holmes, J.A. Becker, M.C. Limacher, R.L. Page, and C. Sila ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee Circulation 124 2011 1290 1310
-
(2011)
Circulation
, vol.124
, pp. 1290-1310
-
-
Holmes, D.R.1
Becker, J.A.2
Limacher, M.C.3
Page, R.L.4
Sila, C.5
-
22
-
-
84883454028
-
-
Department of Health and Aging Available at: Accessed 20.01.13
-
Department of Health and Aging Australian Government. Schedule of Pharmaceutical Benefits 2013 Available at: http://www.pbs.gov.au/publication/ schedule/2013/01/2013-01-01-pbs-schedule.pdf Accessed 20.01.13
-
(2013)
Australian Government. Schedule of Pharmaceutical Benefits
-
-
-
23
-
-
84883455284
-
Generics substitution in primary care: Summary of the Dutch community pharmacies guidelines
-
L. Grandia, and A. Vulto Generics substitution in primary care: summary of the Dutch community pharmacies guidelines GaBI J 1 2012 102 103
-
(2012)
GaBI J
, vol.1
, pp. 102-103
-
-
Grandia, L.1
Vulto, A.2
-
24
-
-
84873918065
-
-
Royal Dutch Pharmacists Association (KNMP) Available at: Accessed 16.05.13
-
Royal Dutch Pharmacists Association (KNMP) Guideline for Generic Substitution 2012 Available at: http://www.knmp.nl/downloads/producten-diensten/ farmacotherapie/handleiding.geneesmiddelsubstitutie.engels.201202.pdf/view Accessed 16.05.13
-
(2012)
Guideline for Generic Substitution
-
-
-
25
-
-
84883462931
-
-
Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Available at: Accessed 18.05.13
-
Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Data Requirements for Human Drugs Submission: Content of the Dossier (Version 1.1) 2011 Available at: http://www.sfda.gov.sa/en/drug/drug-reg/Regulations/ Data%20Requirements%20for%20Human%20Drugs%20Submission%20version%201.1.pdf Accessed 18.05.13
-
(2011)
Data Requirements for Human Drugs Submission: Content of the Dossier (Version 1.1)
-
-
-
26
-
-
84883446794
-
-
Executive Board of the Health Ministers' Council for GCC States Available at: Accessed 18.05.13
-
Executive Board of the Health Ministers' Council for GCC States The GCC Guidelines for Bioequivalence (version 2.1) 2011 Available at: http://www.sfda.gov.sa/en/drug/drug-reg/Regulations/ GCC%20%20Guidelines%20for%20Bioequivalence-Final%203-2013.pdf Accessed 18.05.13
-
(2011)
The GCC Guidelines for Bioequivalence (Version 2.1)
-
-
-
27
-
-
84883465208
-
-
Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Available at: Accessed 18.05.13
-
Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Registered Drug List 2013 Available at: http://www.sfda.gov.sa/en/drug/Pages/default.aspx Accessed 18.05.13
-
(2013)
Registered Drug List
-
-
-
30
-
-
70849123179
-
Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia
-
C.P. Chong, M.A. Hassali, M.B. Bahari, and A.A. Shafie Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia Health Policy. 94 2010 68 75
-
(2010)
Health Policy.
, vol.94
, pp. 68-75
-
-
Chong, C.P.1
Hassali, M.A.2
Bahari, M.B.3
Shafie, A.A.4
-
31
-
-
77950937059
-
A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia
-
G.N. Chua, M.A. Hassali, A.A. Shafie, and A. Awaisu A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia Health Policy. 95 2010 229 235
-
(2010)
Health Policy.
, vol.95
, pp. 229-235
-
-
Chua, G.N.1
Hassali, M.A.2
Shafie, A.A.3
Awaisu, A.4
-
32
-
-
84876063614
-
Generic substitution in Malaysia: Recommendations from a Systematic Review
-
M.A. Hassali, J. Thambyappa, and F. Saleem Generic substitution in Malaysia: recommendations from a Systematic Review J App Pharm Sc 2 2012 159 164
-
(2012)
J App Pharm Sc
, vol.2
, pp. 159-164
-
-
Hassali, M.A.1
Thambyappa, J.2
Saleem, F.3
-
33
-
-
80053916376
-
Generic and therapeutic substitution: A viewpoint on achieving best practice in Europe
-
A. Johnston, R. Asmar, and B. Dahlöf Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe Br J Clin Pharmacol 72 2011 727 730
-
(2011)
Br J Clin Pharmacol
, vol.72
, pp. 727-730
-
-
Johnston, A.1
Asmar, R.2
Dahlöf, B.3
|